All In Biotech

Drug Trial Radar · NCT01946984

Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis

Intramuscular Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial, In Post ERCP Pancreatitis.

Last checked: Nov 20, 2026Latest source record: Sep 20, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 182 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

182

Actual

Start

Jun 2012

Primary completion

Jun 2013

Study completion Jun 2013

Sponsor

Lead sponsor
Specialized Arab HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 20, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Prevention
Who can join
All sexes, from 16 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

1. The most common complication of endoscopic retrograde cholangio-pancreaticography (ERCP) is pancreatitis. 2. Several studies showed that non-steroidal anti-inflammatory drugs (NSAIDs) can prevent the post ERCP pancreatitis, the investigators used diclofenac vs placebo. 3. The effect of diclofenac in prevention of that complication, was measured by the number of patients who developed pancreatitis, and compare it with the placebo. 4. The investigators collected 199 patients, 17 excluded, 182 completed the study, all of them underwent the intervention called "ERCP", and randomized to have either Diclofenac or Placebo before the procedure.

Conditions

  • Post-ERCP Acute Pancreatitis.

Interventions

  • ERCPProcedure

    endoscopy, retrograde cholangio-pancreaticography.

  • Diclofenac hydroxyethylpyrrolidineDrug

  • Normal SalineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. prevention of pancreatitis,Time frame: within a week after procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • SAH hospital

    Nablus, West Bank, Palestinian Territories

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.